Share

    


Home / Search Results

Search Results

You searched for:

Dr. Barbara Schmidtman highlights key findings from the 2022 ACCC Mini Z burnout survey, comparing results from the pre-pandemic 2019 to now.
In addition to the global pandemic, ongoing lawsuits from referenced biologics' manufacturers suing biosimilar manufacturers are having a negative impact on the development and approval of new biosimilars.
As we turn the corner toward 2022, for oncology to drive equity forward: We need every member and every discipline, patient, leader, payer, industry partner, and innovator working together to provide the most equitable care possible in a sustainable way.
At Northwest Medical Specialties, we, too, face challenges from staff stress and exhaustion. To address and overcome these challenges, our management team has made it a priority to bolster the resiliency of our staff.
In an interview with Oncology Issues, Dr. Weiss shares why she believes this work is important in all levels of healthcare—from the clinic to the boardroom.
The Hospital Outpatient Prospective Payment System (HOPPS) for calendar year 2022.
There has been a flurry of activity from the Centers for Medicare & Medicaid Services, Health and Human Services, and Health Resources and Services Administration, including the release of the CMS calendar year (CY) 2022 proposed rules for the Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment System. Below is a summary of how these notifications may impact oncology.